Agilent Technologies in $2.2 Billion Acquisition of Dako

Cleary Gottlieb is representing Agilent Technologies, Inc. in its $2.2 billion acquisition of Danish cancer diagnostics company Dako A/S from EQT, the Sweden-based private equity group.

The transaction, which was announced on May 17 and is Agilent’s largest ever acquisition, is expected to close within 60 days pending regulatory clearances.

Agilent is the world’s premier measurement company and a technology leader in chemical analyses, life sciences, electronics and communication. Dako is a global leader in tissue-based cancer diagnostics, providing know-how, reagents, instruments and software to hospitals and research laboratories in more than 100 countries worldwide. Agilent’s strategy in acquiring Dako is to strengthen its presence in life sciences while combining with a complementary company to produce revenue synergies.